The significant association of MAD2L2 with NCOA3 expression revealed in cellular experiments and clinical outcomes led us to further verify the roles of MAD2L2 and NCOA3 in CRC in a mouse xenograft model. Here, MAD2L2 is linked to colorectal carcinoma.